Advantix Dog 600/3000 100 mg/ml - 500 mg/ml Solution pour spot-on
Advantix Dog 600/3000 100 mg/ml - 500 mg/ml Solution pour spot-on
Authorised
- Permethrin
- Imidacloprid
Product identification
Medicine name:
Advantix Dog 600/3000 100 mg/ml - 500 mg/ml Solution pour spot-on
Active substance:
- Permethrin
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Permethrin3000.00/milligram(s)6.00millilitre(s)
-
Imidacloprid600.00/milligram(s)6.00millilitre(s)
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Advantix Dog 600/3000 1 6 ml Pipette Spot-on solution
- Advantix Dog 600/3000 2 6 ml Pipette Spot-on solution
- Advantix Dog 600/3000 3 6 ml Pipette Spot-on solution
- Advantix Dog 600/3000 4 6 ml Pipette Spot-on solution
- Advantix Dog 600/3000 6 6 ml Pipette Spot-on solution
- Advantix Dog 600/3000 24 6 ml Pipette Spot-on solution
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 442/19/07/1765
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet